Dermatology · Monroeville, PA
NPI
1255697272
Since 2012
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2790 Mosside Blvd Ste 720
Monroeville, PA, 15146
Phone (412) 372-2770
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
9,016 services
Medicare patients, 2024
683
Average age 74
Drug cost, 2024
$1.3M
2,563 prescriptions
Company payments, 2025
$1,837
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ezra D Mirvish was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 3,800 times for 19 patients. In total Ezra D Mirvish billed 9,016 services in 60 codes, and Medicare paid $173K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-31.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 3,800 | 19 | $1.32 | $5,009 |
| 17003 Destruction Skin Lesion | Office | 2,011 | 274 | $4.83 | $9,715 |
| 99213 Office E&M - Established | Office | 736 | 555 | $58.81 | $43K |
| 17000 Destruction Skin Lesion | Office | 503 | 366 | $35.17 | $18K |
| 17110 Destruction Skin Lesion | Office | 299 | 242 | $73.84 | $22K |
| 11102 Skin Biopsy | Office | 286 | 252 | $58.36 | $17K |
| 99214 Office E&M - Established | Office | 105 | 72 | $83.86 | $8,805 |
| 11103 Skin Biopsy | Office | 94 | 68 | $37.24 | $3,500 |
| 99203 Office E&M - New | Office | 77 | 77 | $62.24 | $4,793 |
| 99212 Office E&M - Established | Office | 75 | 59 | $39.44 | $2,958 |
| 17004 Destruction Skin Lesion | Office | 63 | 47 | $118.03 | $7,436 |
| 17262 Destruction Skin Lesion | Office | 21 | 20 | $123.91 | $2,602 |
| 96574 Skin | Office | 19 | 19 | $165.15 | $3,138 |
| 11301 Removal or Shaving of Skin Growth | Office | 17 | 16 | $79.94 | $1,359 |
| 12032 Wound Repair - All Levels | Office | 16 | 16 | $227.35 | $3,638 |
By year: 2022 $148K for 5,328 services; 2023 $165K for 7,512 services; 2024 $173K for 9,016 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ezra D Mirvish prescribed most often to Medicare patients was Ketoconazole, with 354 prescriptions and refills. In total Ezra D Mirvish wrote 2,563 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 354 | 373 | 178 | $3,806 |
| Clobetasol Propionate Generic | 273 | 293 | 161 | $8,953 |
| Triamcinolone Acetonide Generic | 219 | 250 | 130 | $2,599 |
| Hydrocortisone Generic | 189 | 201 | 118 | $1,000 |
| Selenium Sulfide Generic | 165 | 168 | 82 | $1,962 |
| Clotrimazole Generic | 117 | 120 | 71 | $956 |
| Ciclopirox Ciclopirox Olamine | 96 | 104 | 54 | $1,547 |
| Ciclopirox Generic | 91 | 91 | 37 | $2,983 |
| Doxycycline Hyclate Generic | 76 | 82 | 35 | $1,338 |
| Mupirocin Generic | 74 | 74 | 51 | $448 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 72 | 76 | 43 | $2,073 |
| Finasteride Generic | 70 | 177 | 22 | $771 |
| Tacrolimus Generic | 63 | 63 | 52 | $5,542 |
| Otezla Apremilast | 60 | 60 | Under 11 | $269K |
| Clindamycin Phosphate Generic | 52 | 52 | 16 | $1,606 |
Brand drugs: 225 claims; generic drugs: 2,338 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ezra D Mirvish $1,837 ($1,837 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $532.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 56 | $532 |
| Genzyme Corporation SNY | 17 | $412 |
| LEO Pharma Inc. | 24 | $258 |
| Lilly USA, LLC LLY | 13 | $188 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $167 |
| Organon LLC OGN | 6 | $59.49 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $53.96 |
| UCB, Inc. UCB.BR | 2 | $44.19 |
| Biofrontera Inc. | 1 | $21.85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.